Zobrazeno 1 - 3
of 3
pro vyhledávání: ''
Autor:
Premal Patel, George Daniel Radavoi, Albert Font, Kent C. Shih, Johann S. de Bono, Wai Y. Chan, Jose Angel Arranz Arija, Daniel Nava Rodrigues, N. Xu, Han Ma, Viorel Jinga, Steven Gendreau, Christophe Massard, Ugo De Giorgi, Ruth Riisnaes, Daniel J. Maslyar, Sergio Bracarda
Publikováno v:
Clinical Cancer Research
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Purpose: PI3K–Akt–mTOR and androgen receptor (AR) signaling are commonly aberrantly activated in metastatic castration-resistant prostate cancer (mCRPC), with PTEN loss associating with poor prognosis. We therefore conducted a phase Ib/II study o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95541e8fd7286e6e27d416083a6fb078
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4072
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4072
Autor:
Elena Fumagalli, Georgios Antoniou, Axel Le Cesne, Mehdi Brahmi, Jean-Yves Blay, Angelo Paolo Dei Tos, Olivier Mir, Armelle Dufresne, Marta Sbaraglia, Paolo G. Casali, Paola Collini, Giovanni Fucà, Roberta Sanfilippo, Federica Grosso, Alesandro Gronchi, Rossella Bertulli, Nadia Hindi, Robin L. Jones, Silvia Stacchiotti, Salvatore Provenzano
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
Purpose: Perivascular epitheliod cell tumors (PEComas) are rare mesenchymal neoplasms for which the role of systemic treatments is not established as there are no published prospective clinical trials or sufficiently large retrospective case series.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ea10d5b5097f26f683be605028c4999
http://hdl.handle.net/10261/212723
http://hdl.handle.net/10261/212723
Autor:
Eleni Frangou, Hani Gabra, Shirley Wong, Tarek Meniawy, Linda Mileshkin, Euan A. Stronach, Sarah P. Blagden, Prashanth Gopalakrishna, Alla Lisyanskaya, Jeffrey C. Goh, Michelle DeSilvio, Marcia Hall, Agnieszka Michael, Anne Hamilton
Purpose: Preclinically, AKT kinase inhibition restores drug sensitivity in platinum-resistant tumors. Here the pan-AKT kinase inhibitor afuresertib was given in combination with paclitaxel and carboplatin (PC) in patients with recurrent platinum-resi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::320d1a6389366b2b69fefa0d7122608f
http://hdl.handle.net/10044/1/70592
http://hdl.handle.net/10044/1/70592